Almac To Create Over 1,000 New Jobs Across NI

Pharmaceutical development and manufacturing organisation, Almac Group, has announced the creation of more than 1,000 new jobs across Northern Ireland.

The jobs are part of a three-year global recruitment drive to hire 1,800 new staff across 120 different roles.

The Craigavon-based company, which marked 50 years in business in 2018, is at the forefront of the development, manufacturing, testing and distribution of essential medicines to vulnerable patients across the globe. Over the past 18 months, Almac has been instrumental in providing support to over 140 separate crucial research projects for COVID-19 vaccines and treatments through a range of service areas.

Almac Group has experienced continued growth in revenue and employee numbers annually over the past 15 years and with significant investment in expansion projects planned over the next three years, the company will see its headcount rise to 8,000 across its 19 facilities globally. Earlier this year the Group reported £677.3 million turnover for its financial year 2019/20 – an increase of £43 million (6%) from the previous year.

With 100% of the Group's profits reinvested into the business, Almac has already committed to a number of significant expansion and improvement projects across its sites. These new roles will support this ongoing investment.

Alan Armstrong, Almac Group CEO, commented: "Almac's mission is to "advance human health" and we are proud to be supporting so many global clients as they develop their life-saving treatment for patients in need.

He continued: "As demand for our services steadily increases, our aim is to continue to grow our global team by actively recruiting 1,800 new individuals across a wide variety of diverse and exciting areas. These roles come with a range of benefits including flexible working, competitive salary and an annual bonus. Crucially this offers individuals the chance to help us continue our provision of solutions whilst making a real and positive contribution to health right across the world."